UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

The Role of the Glycemic Index and Glycemic Load in the Dietary Approach of Gestational Diabetes Mellitus

Nutrients, 2024-01, Vol.16 (3), p.399

2024

Link zum Volltext

Verfügbarkeit prüfen

HLA variations in patients with diffuse large B-cell lymphoma and association with disease risk and prognosis: a case-control study

Frontiers in genetics, 2024, Vol.15, p.1341822-1341822

2024

Link zum Volltext

Verfügbarkeit prüfen

Development of a novel PTD-mediated IVT-mRNA delivery platform for potential protein replacement therapy of metabolic/genetic disorders

Molecular therapy. Nucleic acids, 2021-12, Vol.26, p.694-710

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center

Journal of clinical medicine, 2022-02, Vol.11 (4), p.937

2022

Link zum Volltext

Verfügbarkeit prüfen

Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease

World journal of hepatology, 2024-05, Vol.16 (5), p.671-677

2024

Link zum Volltext

Verfügbarkeit prüfen

Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease

Alimentary pharmacology & therapeutics, 2024-08, Vol.60 (4), p.540-541

2024

Link zum Volltext

Verfügbarkeit prüfen

Endocrinopathies in beta thalassemia: a narrative review

Hormones (Athens, Greece), 2024-06, Vol.23 (2), p.205-216

2024

Link zum Volltext

Verfügbarkeit prüfen

Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report

International journal of hematology, 2008-10, Vol.88 (3), p.341-342

2008

Link zum Volltext

Verfügbarkeit prüfen

Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece

Hemoglobin, 2022-03, Vol.46 (2), p.143-145

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Effects of Different Long-term Iron-Chelation Regimens on Myocardial and Hepatic Iron Concentrations Assessed with T2 Magnetic Resonance Imaging in Patients with β-Thalassemia Major

International journal of hematology, 2007-12, Vol.86 (5), p.385-389

2007

Link zum Volltext

Verfügbarkeit prüfen

Safety of deferasirox in sickle cell disease patients with co-existing liver impairment

British journal of haematology, 2012-05, Vol.157 (4), p.505-506

2012

Link zum Volltext

Verfügbarkeit prüfen

Diffuse gastric plasmacytoma involvement in multiple myeloma

Endoscopy, 2015-01, Vol.47 Suppl 1 UCTN, p.E197

2015

Link zum Volltext

Verfügbarkeit prüfen

Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience

Annals of hematology, 2013-01, Vol.92 (2), p.263-265

2013

Link zum Volltext

Verfügbarkeit prüfen

Severe Sickle Cell Disease Is Characterized by Low ADAMTS13/VWF: Ag Ratio

Blood, 2012-11, Vol.120 (21), p.3235-3235

2012

Link zum Volltext

Verfügbarkeit prüfen

MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations

European journal of haematology, 2009-05, Vol.82 (5), p.388-392

2009

Link zum Volltext

Verfügbarkeit prüfen

Is liver stiffness really unrelated to liver iron concentration?

British journal of haematology, 2010-07, Vol.150 (2), p.247-248

2010

Link zum Volltext

Verfügbarkeit prüfen

Restrictive pulmonary dysfunction and its predictors in young patients with β-thalassaemia major

Pediatric pulmonology, 2012-08, Vol.47 (8), p.801-807

2012

Link zum Volltext

Verfügbarkeit prüfen

β-Thalassemia and renal complications. A narrative review of pathophysiologic mechanisms

Integrative molecular medicine, 2018, Vol.5 (4)

2018

Link zum Volltext

Verfügbarkeit prüfen

Occurrence of Neoplastic Diseases in a Large Cohort of Thalassemic Patients in Greece

Blood, 2012-11, Vol.120 (21), p.3264-3264

2012

Link zum Volltext

Verfügbarkeit prüfen

Serum Uric Acid As a Predictor Factor of the Response to Deferasirox Therapy for Patients with b-Thalassemia Major

Blood, 2011-11, Vol.118 (21), p.5306-5306

2011

Link zum Volltext

Verfügbarkeit prüfen

No Correlation Between Myocardial T2 and Right Ventricular Function in Thalassemia Major. A Single Centre Four Years Experience

Blood, 2011-11, Vol.118 (21), p.5308-5308

2011

Link zum Volltext

Verfügbarkeit prüfen

Combined Chelation Therapy with Deferoxamine and Deferiprone in β-Thalassemia Major: Compliance and Opinions of Young Thalassemic Patients

Hemoglobin, 2014-01, Vol.38 (2), p.111-114

2014

Link zum Volltext

Verfügbarkeit prüfen

Deferiprone-related arthropathy of the knee in a thalassemic patient: report of a case and review of the literature

Clinical rheumatology, 2008-11, Vol.27 (11), p.1459-1461

2008

Link zum Volltext

Verfügbarkeit prüfen

comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2 magnetic resonance imaging in patients with beta-thalassemia major

International journal of hematology, 2007-12, Vol.86 (5), p.385-389

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Humans
(22)
Male
(19)
Female
(17)
Adult
(16)
Hematology
(13)
Adolescent
(9)
Beta-Thalassemia - Drug Therapy
(7)
Child
(7)
Sickle Cell Disease
(7)
Deferiprone
(6)
Beta-Thalassemia - Complications
(5)
Hemoglobinopathies
(5)
Iron Chelating Agents - Therapeutic Use
(5)
Magnetic Resonance Imaging
(5)
Medicine
(5)
Medicine & Public Health
(5)
Thalassemia
(5)
Young Adult
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Role of the Glycemic Index and Glycemic Load in the Dietary Approach of Gestational Diabetes Mellitus

HLA variations in patients with diffuse large B-cell lymphoma and association with disease risk and prognosis: a case-control study

Development of a novel PTD-mediated IVT-mRNA delivery platform for potential protein replacement therapy of metabolic/genetic disorders

Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center

Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease

Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease

Endocrinopathies in beta thalassemia: a narrative review

Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report

Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece

Comparison of Effects of Different Long-term Iron-Chelation Regimens on Myocardial and Hepatic Iron Concentrations Assessed with T2 Magnetic Resonance Imaging in Patients with β-Thalassemia Major

Safety of deferasirox in sickle cell disease patients with co-existing liver impairment

Diffuse gastric plasmacytoma involvement in multiple myeloma

Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients

Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience

Severe Sickle Cell Disease Is Characterized by Low ADAMTS13/VWF: Ag Ratio

MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations

Is liver stiffness really unrelated to liver iron concentration?

Restrictive pulmonary dysfunction and its predictors in young patients with β-thalassaemia major

β-Thalassemia and renal complications. A narrative review of pathophysiologic mechanisms

Occurrence of Neoplastic Diseases in a Large Cohort of Thalassemic Patients in Greece

Serum Uric Acid As a Predictor Factor of the Response to Deferasirox Therapy for Patients with b-Thalassemia Major

No Correlation Between Myocardial T2 and Right Ventricular Function in Thalassemia Major. A Single Centre Four Years Experience

Combined Chelation Therapy with Deferoxamine and Deferiprone in β-Thalassemia Major: Compliance and Opinions of Young Thalassemic Patients

Deferiprone-related arthropathy of the knee in a thalassemic patient: report of a case and review of the literature

comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2 magnetic resonance imaging in patients with beta-thalassemia major

Suchergebnisse filtern